Breaking: NAFDAC Approves AstraZeneca Covid-19 Vaccine For Use In Nigeria — A health worker prepares an injection of the AstraZeneca/Oxford Covid-19 vaccine of February 7, 2021 at the Mignot Hospital in Le Chesney near Paris. The top French medical authority Haute autorite de Dante has approved the vaccine for use in France, but only for people under 65, echoing decisions made in Sweden ,Germany, Switzerland and Belgium over concerns about lack of data on the effectiveness of the vaccine for over 65s. Photo: ALAIN JOCARD/AFP

The Oxford/AstraZeneca COVID-19 vaccine has been approved for use by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria.

The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).

No Result